Effects of Trunk Postural Change on CO2 Removal Efficiency in ARDS Patients: Quasi-experimental Study
NCT ID: NCT05281536
Last Updated: 2022-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2021-04-01
2022-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
DESIGN: Quasi-experimental study. SETTING: A medical ICU in Chile. PATIENTS: Twenty-two patients with ARDS. INTERVENTION: Patients in pressure-controlled ventilation underwent three 60-minute steps in which trunk inclination was changed from 45° (baseline) to 10° (intervention) and back to 45° (control) in the last step. Respiratory mechanics, arterial blood gas analysis, dead space by volumetric capnography, and electrical impedance tomography were recorded.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Continuous Prolonged Prone Position Versus Intermittent Daily Prone Position in ARDS
NCT06854627
Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
NCT05535543
Prone Positioning and Abdominal Binding on Lung and Muscle Protection in ARDS Patients During Spontaneous Breathing
NCT05826847
Physiological Studies in the Prone Position in Patients With ARDS
NCT06586736
Role of Pulmonary Perfusion on Tolerance to Supine Position in Patients With ARDS
NCT05408442
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Consistently, driving pressure and respiratory system compliance (CRS) increase has been found when bed angulation is increased at 40 - 45 degrees. Besides, most patients in the semi-recumbent position rising end-expiratory lung volume (EELV) and oxygenation. These findings continue to raise questions regarding the physiological mechanisms underlying these effects.
On the other side, changing trunk tilt to zero degrees in patients with COVID-19 related ARDS reduced the ventilatory ratio and partial pressure of carbon dioxide (PaCO2). In addition, when patients were placed in a lying-flat position at 0°, the driving pressure and lung compliance declined, generating lower energy applied to the lung. This way, an alveolar overdistention reduction could explain the improvement in the kinetics of CO2 but is not fully elucidated, mainly due to the short evaluation period and the low accuracy of the ventilatory ratio to measure the lung efficiency to exhale CO2. It should be noted that one of the best ways to assess ventilatory efficiency physiologically is with volumetric capnography (8), but this technology has never been used when chest inclination changes in ARDS patients.
Thus, we hypothesized that changes in trunk inclination to a lying-flat position in ARDS patients connected to mechanical ventilation would improve CO2 removal efficiency. Therefore, the primary objective of this study was to assess the effects of postural change from 45° to 10° bed tilt on CO2 exhaled per minute (VCO2), Bohr's dead space (VDBohr/VT) and PaCO2. The secondary objective was to evaluate the lung volume effects and the ventilation distribution in the different lung regions.
Study steps:
step I: Baseline conditions. Patient in the semi-recumbent position at 45° head-up, and lower extremities parallel to the floor.
step II: Intervention phase with a trunk postural change at 10° in lying supine position.
step III: Control phase with a return to the semi-recumbent position at 45° head-up.
Five minutes before each step, PaCO2, and partial pressure of arterial oxygen over the fraction of inspired oxygen (PaO2/FIO2) were recorded. Both tidal volume (VT), volumetric capnography and Electrical impedance tomography (EIT) variables were analyzed offline using the mean value of the last 20 breaths of the last three minutes of each step. Haemodynamic variables and pulse oximetry were continuously monitored (Multiparameter Spacelabs 91393 Xprezzon®).
Security procedure:
Therapeutic interventions were kept strictly unchanged during all evaluation periods. The following criteria were predefined to interrupt the study protocol if required: desaturation corresponding to a drop of more than 10% of baseline oxygen saturation value; drop in mean arterial pressure of more than 20% of baseline value or heart rate increase of more than 20 % of baseline values.
Primary outcomes:
VDBohr/VT and PaCO2 reduction at 60 minutes of trunk change to 10° concerning the body position in basal conditions of 45°.
Statistical analysis:
Different assumptions were made for a repeated sample study. We considered as clinically significant effect, a mean reduction of 5 mmHg with a standard deviation of ± 3 mmHg of PaCO2 with a power of 90% and a probability of type I error of 0.01. Based on these assumptions, the sample size was 22 participants.
The Shapiro-Wilk test was performed to determine the distribution of continuous variables while homoscedasticity was tested using the Levene test. According to their distribution, continuous variables were expressed as mean and standard deviation or median and interquartile range. Parametric versus non-parametric tests were decided according to the data distribution and whether the assumption of normality was met. Continuous variables were analyzed by ANOVA for repeat measure, or the Friedman test was applied, as appropriate. Bonferroni and Dunn's post hoc were used for the comparison between step II-step I, step III-step I and step III-step II, respectively.
T-test was used to measure the median difference and 95% confidence interval (95% CI) between step I and step II. Wilcoxon rank test was performed to evaluate changes in ventral or dorsal end-expiratory lung impedance (EELI) and tidal variation of impedance (VTI) from 45 to 10 degrees.
A two-tailed p-value less than 0.05 was considered statistically significant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
The results will be analyzed by statisticians, who will not know the participant's identification
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Postural Changes from 45° to 10° in supine decubitus
Postural changes from 45° to 10° in supine decubitus Three times of 60 minutes each step before (45°, baseline) - during (10°, intervention) - after (45°, control)
Ppostural change from 45° to 10° in supine position
The intervention will be a postural change from 45° to 10° in a semi-recumbent position of ARDS patients connected to mechanical ventilation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ppostural change from 45° to 10° in supine position
The intervention will be a postural change from 45° to 10° in a semi-recumbent position of ARDS patients connected to mechanical ventilation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Admitted to Intensive Care with mild, moderate, or severe ARDS according to the Berlin classification
3. Less than 72 hours of connection to mechanical ventilation.
4. Depth Sedation-analgesia.
5. Acceptance by the legal representative to participate in the study.
Exclusion Criteria
2. Prone position
3. Hypovolemic shock with active bleeding.
4. Intracranial hypertension.
5. Gastric residue greater than 300 ml in the last 6 hours
6. Hemodynamic instability that requires a progressive increase in the dose of vasopressors
7. Temperature variations greater than 0.5 ° C in the last 2 hours
8. Acute heart failure
9. Chronic respiratory disease (FEV1 \<50% predicted).
10. Patients who do not have an arterial line.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clinica las Condes, Chile
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martín Benites, MD
Role: PRINCIPAL_INVESTIGATOR
Clínica Las Condes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clínica Las Condes
Santiago, Santiago Metropolitan, Chile
Martín Hernán Benites
Santiago, Santiago Metropolitan, Chile
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Marrazzo F, Spina S, Forlini C, Guarnieri M, Giudici R, Bassi G, Bastia L, Bottiroli M, Fumagalli R, Langer T. Effects of Trunk Inclination on Respiratory Mechanics in Patients with COVID-19-associated Acute Respiratory Distress Syndrome: Let's Always Report the Angle! Am J Respir Crit Care Med. 2022 Mar 1;205(5):582-584. doi: 10.1164/rccm.202110-2360LE. No abstract available.
Tusman G, Gogniat E, Bohm SH, Scandurra A, Suarez-Sipmann F, Torroba A, Casella F, Giannasi S, Roman ES. Reference values for volumetric capnography-derived non-invasive parameters in healthy individuals. J Clin Monit Comput. 2013 Jun;27(3):281-8. doi: 10.1007/s10877-013-9433-x. Epub 2013 Feb 7.
Mentzelopoulos SD, Roussos C, Zakynthinos SG. Static pressure volume curves and body posture in acute respiratory failure. Intensive Care Med. 2005 Dec;31(12):1683-92. doi: 10.1007/s00134-005-2838-3. Epub 2005 Oct 26.
Rehder K. Postural changes in respiratory function. Acta Anaesthesiol Scand Suppl. 1998;113:13-6. doi: 10.1111/j.1399-6576.1998.tb04980.x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E012021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.